SILO PHARMA, INC. Investment Income, Net
SILO PHARMA, INC. (SILO) reported Investment Income, Net of $11.54 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-05-17.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2021-08-13
- SILO PHARMA, INC. investment income, net for the quarter ending 2020-12-31 was $2.75K, a 10.17% decline year-over-year.
- SILO PHARMA, INC. investment income, net for the quarter ending 2020-09-30 was $2.82K, a 8.60% decline year-over-year.
- SILO PHARMA, INC. investment income, net for the quarter ending 2020-06-30 was $2.94K, a 3.48% decline year-over-year.
- SILO PHARMA, INC. investment income, net for the quarter ending 2020-03-31 was $3.03K, a 1.00% increase year-over-year.
- SILO PHARMA, INC. investment income, net for fiscal 2020 was $11.54K, a 5.35% decline from fiscal 2019.
- SILO PHARMA, INC. investment income, net for fiscal 2019 was $12.20K, a 189.14% increase from fiscal 2018.
- SILO PHARMA, INC. investment income, net for fiscal 2018 was $4.22K, a 79.41% decline from fiscal 2017.
- SILO PHARMA, INC. investment income, net for fiscal 2017 was $20.48K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2020-12-31 | $2.75K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $5.57K derived: sum of 2 quarters · filed 2021-05-17 | $8.51K derived: sum of 3 quarters · filed 2021-08-13 | $11.54K 10-K/A · filed 2021-05-17 |
| 2020-09-30 | $2.82K 10-Q · filed 2020-11-05 | $5.75K derived: sum of 2 quarters · filed 2021-08-13 | $8.79K 10-Q · filed 2020-11-05 | $11.86K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-06-30 | $2.94K 10-Q · filed 2021-08-13 | $5.97K 10-Q · filed 2021-08-13 | $9.04K derived: sum of 3 quarters · filed 2021-08-13 | $12.12K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $3.03K 10-Q · filed 2021-05-17 | $6.10K derived: sum of 2 quarters · filed 2021-05-17 | $9.18K derived: sum of 3 quarters · filed 2021-05-17 | $12.23K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $3.07K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $6.15K derived: sum of 2 quarters · filed 2021-05-17 | $9.19K derived: sum of 3 quarters · filed 2021-05-17 | $12.20K 10-K/A · filed 2021-05-17 |
| 2019-09-30 | $3.08K 10-Q · filed 2020-11-05 | $6.13K derived: sum of 2 quarters · filed 2020-11-05 | $9.13K 10-Q · filed 2020-11-05 | $13.30K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $3.04K 10-Q · filed 2020-08-14 | $6.05K 10-Q · filed 2020-08-14 | $10.22K derived: sum of 3 quarters · filed 2020-08-14 | $10.24K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $3.00K 10-Q · filed 2020-05-12 | $7.18K derived: sum of 2 quarters · filed 2020-05-12 | $7.20K derived: sum of 3 quarters · filed 2020-05-12 | $7.21K derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | $4.17K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $4.19K derived: sum of 2 quarters · filed 2020-03-20 | $4.21K derived: sum of 3 quarters · filed 2020-03-20 | $4.22K 10-K · filed 2020-03-20 |
| 2018-09-30 | $18.00 10-Q · filed 2019-11-13 | $36.00 derived: sum of 2 quarters · filed 2019-11-13 | $44.00 10-Q · filed 2019-11-13 | $49.00 derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $18.00 10-Q · filed 2019-08-13 | $26.00 10-Q · filed 2019-08-13 | $31.00 derived: sum of 3 quarters · filed 2019-08-13 | $6.54K derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $8.00 10-Q · filed 2019-05-14 | $13.00 derived: sum of 2 quarters · filed 2019-05-14 | $6.52K derived: sum of 3 quarters · filed 2019-05-14 | |
| 2017-12-31 | $5.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-04 | $6.51K derived: sum of 2 quarters · filed 2019-04-04 | $20.48K 10-K · filed 2019-04-04 | |
| 2017-09-30 | $6.50K 10-Q · filed 2018-11-14 | $20.48K 10-Q · filed 2018-11-14 | ||
| 2013-12-31 | $600.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |